OTC Products - Eastern Africa

Eastern Africa

Highlights

The OTC Products market in Eastern Africa is projected to reach a revenue of US$2.90bn in 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 3.99%, leading to a market volume of US$3.53bn by 2029.
When compared globally, China is anticipated to generate the highest revenue in the OTC Products market, with an estimated value of US$74.91bn in 2024.
In terms of per person revenues, the OTC Products market in Eastern Africa is projected to generate US$6.33 in 2024.
Eastern Africa is experiencing a growing demand for OTC products due to increasing healthcare awareness and accessibility.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The OTC Products (Pharmacies) market in Eastern Africa has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Eastern Africa have played a crucial role in driving the growth of the OTC Products (Pharmacies) market. Consumers in this region have shown a growing interest in self-medication and taking control of their own health. This shift in consumer behavior has led to an increased demand for over-the-counter products, as people seek accessible and affordable healthcare solutions. Additionally, the rising awareness of preventive healthcare and the importance of maintaining a healthy lifestyle have further fueled the demand for OTC products. Trends in the market have also contributed to the growth of the OTC Products (Pharmacies) market in Eastern Africa. One notable trend is the increasing availability of OTC products in pharmacies and retail outlets across the region. This expansion of distribution channels has made OTC products more accessible to a larger population, driving up sales. Furthermore, the rise of e-commerce platforms and online pharmacies has further expanded the reach of OTC products, allowing consumers to conveniently purchase them from the comfort of their own homes. Local special circumstances have also played a role in the development of the OTC Products (Pharmacies) market in Eastern Africa. The region has a high burden of communicable diseases, such as malaria and HIV/AIDS, which has led to an increased demand for OTC products that help manage the symptoms and provide relief. Additionally, the lack of access to healthcare facilities and trained medical professionals in some areas has further emphasized the importance of OTC products as a primary source of healthcare for many individuals. Underlying macroeconomic factors have also contributed to the growth of the OTC Products (Pharmacies) market in Eastern Africa. The region has been experiencing steady economic growth, leading to an increase in disposable income among consumers. This rise in purchasing power has allowed individuals to afford OTC products, further driving the demand. Additionally, the growing middle class in Eastern Africa has resulted in an increased focus on personal health and wellness, leading to a higher demand for OTC products. In conclusion, the OTC Products (Pharmacies) market in Eastern Africa has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for self-medication, the availability of OTC products, the high burden of communicable diseases, and the region's economic growth have all contributed to the development of this market. As the region continues to progress, it is expected that the OTC Products (Pharmacies) market will continue to thrive.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.